10x Genomics Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
10x Genomics (TXG) Misses Q3 EPS by 35c, Revenues Beat
November 10, 2020 4:25 PM EST10x Genomics (NASDAQ: TXG) reported Q3 EPS of ($0.65), $0.35 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $71.8 million versus the consensus estimate of $61.23 million.
Recent Highlights
Revenue was $71.8 million for the third quarter, representing a 17% increase over the... More


